Correlation between Beta1 integrin expression and prognosis in clinically localized prostate cancer

Pontes-Junior, Jose; Reis, Sabrina Thalita; Bernardes, Felipe S.; Oliveira, Luiz C. N.; Barros, Erika Aparecida Felix de; Dall'oglio, Marcos Francisco; Timosczuk, Luciana M. S.; Ribeiro-Filho, Leopoldo A.; Srougi, Miguel; Leite, Katia R. M..
Int. braz. j. urol ; 39(3): 335-343, May/June/2013. tab, graf
Artículo en Inglés | LILACS | ID: lil-680084

Documentos relacionados

  1. Preanalytical stability of molecular forms of prostate-specific antigen in serum samples (PSA, free PSA, [-2]proPSA) and their impact on fPSA/tPSA ratio and PHI.
  2. Molecular margin status after radical prostatectomy using glutathione S-transferase P1 (GSTP1) promoter hypermethylation.
  3. Prediction of clinically significant prostate cancer through urine metabolomic signatures: A large-scale validated study.
  4. Validation of schedules for optimal prostate-specific antigen monitoring after radical prostatectomy.
  5. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy.
  6. Predictive value of kallikrein forms and ß-microseminoprotein in blood from patients with evidence of detectable levels of PSA after radical prostatectomy.
  7. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis, and Future Directions.
  8. Association of plasma NRP2 and VEGF-C levels with prostate cancer disease severity.
  9. Index tumor location affected early biochemical recurrence after radical prostatectomy in patients with negative surgical margin: a retrospective study.
  10. Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer.